ArticleNPJ vaccines2026

A double-blinded, placebo-controlled field trial of an OspA-based oral reservoir targeted vaccine against Borrelia burgdorferi.

Amy M Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.